(Q46063040)

19 December 2017

title

Hydroxycarbamide in combination with azacitidine or decitabine is antagonistic on DNA methylation inhibition (English)

1 reference

19 December 2017

0 references

1 reference

2

1 reference

19 December 2017

author name string

Si Ho Choi

1

1 reference

19 December 2017

Jennifer M Kwan

3

1 reference

19 December 2017

Jean-Pierre J Issa

4

1 reference

19 December 2017

Allen S Yang

5

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

19 December 2017

British Journal of Haematology

published in

1 reference

19 December 2017

volume

138

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

616-623

1 reference

19 December 2017

5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

Increase in Ara-C sensitivity in Ara-C sensitive and -resistant leukemia by stimulation of the salvage and inhibition of the de novo pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

Pharmacokinetics and pharmacodynamics of hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

Cellular differentiation, cytidine analogs and DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

Sickle cell anemia and antisickling agents then and now.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

Epigenetic therapy of cancer: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06707.X

10.1111/J.1365-2141.2007.06707.X

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017